
Numab Therapeutics AG
Numab Therapeutics AG is a Swiss biotechnology company developing multi-specific antibody-based immunotherapies for the treatment of inflammation and cancer.
/10
Transparency ranking
Work at Numab Therapeutics AG?
Tell us what we're missing about working at Numab Therapeutics AG so we can make the job search more transparent for everyone.
Tell us what it's like to work at Numab Therapeutics AG!Description
Numab Therapeutics AG is a Swiss biotechnology company focused on developing multi-specific antibody-based immunotherapies for inflammation and cancer. They leverage their proprietary λ-Cap™ and MATCH™ technology platforms to overcome traditional drug discovery limitations and create a pipeline of first-in-class and best-in-class medicines. Their lead candidate, NM26, is a unique multi-specific antibody targeting IL-4/13 and IL-31 for the treatment of atopic dermatitis and other potential indications.
Numab's innovative approach has attracted multiple partnerships with leading pharmaceutical companies, validating their platforms and development capabilities. Their commitment to scientific excellence, teamwork, and exceeding expectations creates a fast-paced, science-driven work environment for their employees. Numab is located in Horgen, Switzerland, a picturesque location on Lake Zurich, offering employees a balance of challenging work and attractive surroundings.
Flexibility
Numab Therapeutics AG offers a flexible work environment that values teamwork and excellence. The company fosters a culture that encourages employees to exceed expectations and work across disciplines in an exciting, global setting. While the exact extent of flexibility offered is not specified, the emphasis on a fast-paced, science-driven atmosphere suggests opportunities for employees to be involved in the entire development process and work within a state-of-the-art infrastructure alongside a talented team.
Mission
Numab Therapeutics AG is a biotechnology company focused on developing innovative, multi-specific antibody-based immunotherapies for the treatment of inflammatory and cancerous diseases. Their proprietary platforms, λ-Cap™ and MATCH™, enable the creation of highly differentiated therapeutics, overcoming limitations of existing antibody technologies. The company’s mission is to advance a proprietary pipeline of next-generation immunology and immuno-oncology drugs, spearheading the development of first- and best-in-class high-impact therapeutics that maximize patient benefits.
Culture
Numab Therapeutics AG fosters a fast-paced, science-driven work environment that values teamwork, excellence, and performance. The company prioritizes creating a culture that challenges and motivates employees to exceed expectations and work across disciplines in a global, collaborative setting. Numab encourages its employees to be closely involved in the entire development process and offers opportunities to work in a state-of-the-art infrastructure with a supportive team of colleagues.
Similar companies. But verified.
